ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,383,611 | -28.1% | 2,391,768 | +8.9% | 2.98% | -33.1% |
| Q2 2023 | $22,778,545 | +95.3% | 2,196,581 | +52.4% | 4.46% | +94.7% |
| Q1 2023 | $11,662,390 | -27.4% | 1,441,581 | +41.4% | 2.29% | -27.2% |
| Q4 2022 | $16,053,692 | +0.1% | 1,019,282 | 0.0% | 3.15% | -18.5% |
| Q3 2022 | $16,043,000 | +6.1% | 1,019,282 | -5.9% | 3.86% | +6.5% |
| Q2 2022 | $15,119,000 | -6.9% | 1,083,000 | +14.9% | 3.63% | -7.7% |
| Q1 2022 | $16,248,000 | +39.7% | 942,445 | +17.8% | 3.93% | +52.0% |
| Q4 2021 | $11,632,000 | +29.2% | 800,000 | +60.0% | 2.58% | +23.3% |
| Q3 2021 | $9,000,000 | – | 500,000 | – | 2.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,954,904 | $49,264,000 | 43.26% |
| COMMODORE CAPITAL LP | 1,028,084 | $25,908,000 | 10.32% |
| Foresite Capital Management IV, LLC | 3,399,034 | $85,656,000 | 10.26% |
| VR Adviser, LLC | 3,720,582 | $93,759,000 | 10.17% |
| Parkman Healthcare Partners LLC | 1,709,136 | $43,070,000 | 10.00% |
| Foresite Capital Management V, LLC | 1,258,243 | $31,708,000 | 9.32% |
| Stenahm Asset Managment Ltd | 283,500 | $7,144,000 | 5.04% |
| Samsara BioCapital, LLC | 1,022,612 | $25,770,000 | 4.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 336,737 | $8,486,000 | 4.63% |
| Ghost Tree Capital, LLC | 600,000 | $15,120,000 | 3.55% |